Rheumatoid Arthritis Treatment with Filgotinib: Week 156 Safety and Efficacy Data from a Phase 2b Open-Label Extension Study

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Westhovens, Rene [2 ]
Winthrop, Kevin [3 ]
Lee, Susan [4 ]
Greer, Joy [4 ]
DeZure, Adam [4 ]
An, Di [4 ]
Ye, Lei [4 ]
Sundy, John [4 ]
Besuyen, Robin [5 ]
Meuleners, Luc [5 ]
Alten, Rieke [6 ]
Genovese, Mark [7 ]
机构：
[1] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[2] Univ Hosp, Leuven, Belgium
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[5] Galapagos NV, Mechelen, Belgium
[6] Schlosspark Klin Univ Med, Berlin, Germany
[7] Stanford Univ, Stanford, CA 94305 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
GLPG0634/GS-6034; INHIBITOR;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0550
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Rheumatoid arthritis treatment with filgotinib: Week 156 safety and efficacy data from a phase 2b open-label extension study
    Besuyen, R.
    Kavanaugh, A.
    Westhovens, R.
    Winthrop, K.
    Lee, S.
    Greer, J.
    DeZure, A.
    An, D.
    Ye, L.
    Sundy, J.
    Meuleners, L.
    Alten, R.
    Genovese, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S452 - S452
  • [2] Rheumatoid Arthritis Treatment with Filgotinib: Week 132 Safety Data from a Phase 2b Open-Label Extension Study
    Kavanaugh, Arthur
    Genovese, Mark C.
    Winthrop, Kevin
    Creenwald, Maria
    Ponce, Lucia
    Sosa, Favio Enriquez
    Stanislavchuk, Mykola
    Mazur, Minodora
    Spindler, Alberto
    Cseuz, Regina
    Nikulenkova, Natalya
    Glowacka-Kulesz, Maria
    Szombati, Istvan
    Dudek, Anna
    Mozaffarian, Neelufar
    Greer, Joy
    Kunder, Rebecca
    An, Di
    Meulener, Luc
    Besuyen, Robin
    Alten, Rieke
    Westhovens, Rene
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Long Term Safety of Filgotinib in the Treatment of Rheumatoid Arthritis: Week 84 Data from a Phase 2b Open-Label Extension Study
    Genovese, Mark C.
    Kavanaugh, Arthur
    Winthrop, Kevin
    Greenwald, Maria
    Ponce, Lucia
    Enriquez Sosa, Favio
    Stanislavchuk, Mykola
    Mazur, Minodora
    Spindler, Alberto
    Cseuz, Regina
    Nikulenkova, Natalya
    Glowacka-Kulesz, Maria
    Szombati, Istvan
    Dudek, Anna
    Mozaffarian, Neelufar
    Greer, Joy
    Ding, Xiao
    Harrison, Pille
    Van der Aa, Annegret
    Westhovens, Rene
    Alten, Rieke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] LONG TERM SAFETY OF FILGOTINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: WEEK 108 DATA FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Westhovens, R.
    Alten, R.
    Winthrop, K.
    Greenwald, M.
    Ponce, L.
    Enriquez-Sosa, F.
    Stanislavchuk, M.
    Mazur, M.
    Spindler, A.
    Cseuz, R.
    Nikulenkova, N.
    Glowacka-Kulesz, M.
    Szombati, I.
    Dudek, A.
    Mozaffarian, N.
    Greer, J.
    Kunder, R.
    An, D.
    Harrison, P.
    Van der Aa, A.
    Kavanaugh, A.
    Genovese, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 960 - 961
  • [5] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Gao, Jingjing
    Besuyen, Robin
    Helliwell, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Gladman, Dafna
    Coates, Laura
    Mease, Philip
    van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1066 - 1067
  • [7] LONG TERM SAFETY AND EFFICACY OF FILGOTINIB IN A PHASE 2B OPEN LABEL EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS UP TO 144 WEEKS
    Alten, R.
    Westhovens, R.
    Kavanaugh, A.
    Genovese, M.
    Winthrop, K.
    Greenwald, M.
    Ponce, L.
    Enriquez, F.
    Stanislavchuk, M.
    Mazur, M.
    Spindler, A.
    Cseuz, R.
    Nikulenkova, N.
    Glowacka-Kulesz, M.
    Szombati, I.
    Dudek, A.
    Meuleners, L.
    Tasset, C.
    Harrison, P.
    Van der Aa, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 267 - 267
  • [8] Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
    Kavanaugh, Arthur
    Westhovens, Rene R.
    Winthrop, Kevin L.
    Lee, Susan J.
    Tan, YingMeei
    An, Di
    Ye, Lei
    Sundy, John S.
    Besuyen, Robin
    Meuleners, Luc
    Stanislavchuk, Mykola
    Spindler, Alberto J.
    Greenwald, Maria
    Alten, Rieke
    Genovese, Mark C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1230 - 1238
  • [9] Bimekizumab Safety and Efficacy in Patients with Psoriatic Arthritis: 3-Year Results from a Phase 2b Open-Label Extension Study
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    McInnes, I. B.
    [J]. SWISS MEDICAL WEEKLY, 2021, 151 : S20 - S20
  • [10] BIMEKIZUMAB SAFETY AND EFFICACY IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    Mcinnes, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 779 - 780
12345